SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-022777
Filing Date
2019-09-04
Accepted
2019-09-04 20:32:01
Documents
2
Period of Report
2019-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1508
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4697
  Complete submission text file 0000899243-19-022777.txt   7587
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Bogle Grant C. (Reporting) CIK: 0001646675 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 191075992